Discover 1,725 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,725
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Detroit MI, Royal Oak MI, Ann Arbor MI, Toledo OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Detroit MI, Royal Oak MI, Ann Arbor MI, Toledo OH,
Location: Detroit MI, Ann Arbor MI, Toledo OH, Cleveland OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT00736749
Recruiting
New
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Detroit MI, Cleveland OH, Fairfax VA, Philadelphia PA,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07542704
Phase 1, Recruiting
New
A Phase 1 Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
for
Endometrial Cancer Recurrent, Endometrial Cancer,
Location: Detroit MI, Minneapolis MN, Atlanta GA, Houston TX,
Sponsor: Outpace Bio, Inc.
Sex: Female
Age: 18+
Code: NCT07664735
Phase 1, Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Detroit MI, Columbus OH, Cincinnati OH, Chicago IL,
Sponsor: Fate Therapeutics
Sex: All
Age: 18+
Code: NCT06241456
Phase 1, Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies